This page covers Pregnancy-Induced Hypertension thesis topics across clinical profile, maternal risk factors and severity assessment; laboratory parameters and maternal organ dysfunction; fetal growth, placental function and obstetric Doppler; intrapartum management and maternal outcomes; and immediate perinatal outcomes for MD Obstetrics and Gynaecology candidates. The emphasis is on pregnancy-induced hypertension research topics that can be completed within one thesis period using women already undergoing routine blood-pressure monitoring, laboratory testing, fetal biometry, amniotic-fluid assessment, obstetric Doppler, cardiotocography and delivery care. A shortlisted question should then be converted into a clearly time-anchored obstetrics and gynaecology hypertension protocol and a submission-ready obstetrics and gynaecology synopsis.
Last reviewed and updated: September 2026 · 2026–27 admissions
Clinical Profile, Risk Factors, and Severity Assessment
- Clinical and obstetric profile of women with pregnancy-induced hypertension attending a tertiary care hospital: a cross-sectional observational study.
- Maternal demographic and obstetric risk factors associated with pregnancy-induced hypertension: a case-control study.
- Association of maternal age with severity of pregnancy-induced hypertension: a cross-sectional analytical study.
- Association of parity with severity and clinical presentation of pregnancy-induced hypertension: a cross-sectional analytical study.
- Association of booking status and adequacy of antenatal care with severity of pregnancy-induced hypertension: a comparative cross-sectional study.
- Association of maternal body mass index with severity of pregnancy-induced hypertension: a cross-sectional analytical study.
- Comparison of clinical characteristics and obstetric outcomes in primigravidae and multigravidae with pregnancy-induced hypertension: a comparative cross-sectional study.
- Association of family history of hypertension with occurrence and severity of pregnancy-induced hypertension: a case-control study.
- Association of previous history of hypertensive disorder of pregnancy with pregnancy-induced hypertension in the current pregnancy: a case-control study.
- Comparison of maternal characteristics in women with early-onset and late-onset hypertensive disorders of pregnancy: a comparative cross-sectional study.
- Association of gestational age at onset of hypertension with severity of maternal disease in women with pregnancy-induced hypertension: a cross-sectional analytical study.
- Clinical predictors of progression from gestational hypertension to pre-eclampsia during the index admission or pregnancy: a prospective observational study.
- Association of systolic and diastolic blood pressure levels at presentation with severity of pregnancy-induced hypertension: a cross-sectional analytical study.
- Correlation of mean arterial pressure with clinical severity of pregnancy-induced hypertension: a cross-sectional analytical study.
- Comparison of maternal and obstetric characteristics between women with gestational hypertension and pre-eclampsia: a comparative cross-sectional study.
- Prevalence and pattern of severe features among women admitted with pre-eclampsia: a cross-sectional observational study.
- Clinical factors associated with severe pre-eclampsia among women with pregnancy-induced hypertension: a cross-sectional analytical study.
- Association of interpregnancy interval with pregnancy-induced hypertension among multigravidae: a case-control study.
- Association of multiple pregnancy with severity of hypertensive disorders of pregnancy: a comparative cross-sectional study.
- Development of a clinical risk profile using routinely available maternal characteristics for identifying severe pregnancy-induced hypertension: a cross-sectional analytical study.
Laboratory Parameters and Maternal Organ Dysfunction
- Correlation of platelet count with severity of pre-eclampsia: a cross-sectional analytical study.
- Association of thrombocytopenia with maternal complications in women with pre-eclampsia: a cross-sectional analytical study.
- Correlation of serum uric acid with severity of pregnancy-induced hypertension: a cross-sectional analytical study.
- Diagnostic utility of serum uric acid for identifying severe pre-eclampsia among women with pregnancy-induced hypertension: a diagnostic accuracy study.
- Association of serum creatinine with severity of hypertensive disorders of pregnancy: a cross-sectional analytical study.
- Correlation of serum lactate dehydrogenase levels with severity of pre-eclampsia: a cross-sectional analytical study.
- Association of elevated serum lactate dehydrogenase with maternal complications in pre-eclampsia: a prospective observational study.
- Correlation of aspartate aminotransferase and alanine aminotransferase levels with severity of pre-eclampsia: a cross-sectional analytical study.
- Association of liver enzyme abnormalities with immediate maternal outcomes in severe pre-eclampsia: a prospective observational study.
- Comparison of haematological and biochemical parameters in gestational hypertension and pre-eclampsia: a comparative cross-sectional study.
- Association of haemoglobin concentration and haematocrit with severity of pregnancy-induced hypertension: a cross-sectional analytical study.
- Correlation of serum albumin concentration with severity of pre-eclampsia and proteinuria: a cross-sectional analytical study.
- Association of hypoalbuminemia with maternal complications in women with pre-eclampsia: a prospective observational study.
- Correlation of urine protein-creatinine ratio with severity of pre-eclampsia: a cross-sectional analytical study.
- Diagnostic accuracy of spot urine protein-creatinine ratio for significant proteinuria in women with hypertension in pregnancy using 24-hour urinary protein as the reference standard: a diagnostic accuracy study.
- Comparison of urine dipstick protein estimation and spot urine protein-creatinine ratio in women with suspected pre-eclampsia: a comparative diagnostic study.
- Association of degree of proteinuria with maternal and immediate perinatal outcomes in pre-eclampsia: a prospective observational study.
- Correlation of platelet count, serum lactate dehydrogenase, and liver enzymes with clinical severity of pre-eclampsia: a cross-sectional analytical study.
- Laboratory predictors of HELLP syndrome among women with severe pre-eclampsia: a cross-sectional analytical study.
- Association of routinely available renal, hepatic, and haematological parameters with maternal complications in severe hypertensive disorders of pregnancy: a prospective observational study.
Foetal Growth, Placental Function, and Obstetric Doppler
- Prevalence of foetal growth restriction among pregnancies complicated by pregnancy-induced hypertension: a cross-sectional observational study.
- Association of severity of maternal hypertension with foetal growth restriction: a cross-sectional analytical study.
- Comparison of foetal biometry in women with gestational hypertension and pre-eclampsia: a comparative cross-sectional study.
- Association of gestational age at onset of pre-eclampsia with foetal growth restriction: a cross-sectional analytical study.
- Correlation of maternal blood pressure severity with estimated foetal weight in pregnancies complicated by pre-eclampsia: a cross-sectional analytical study.
- Association of placental location with severity of pregnancy-induced hypertension: a cross-sectional analytical study.
- Ultrasonographic placental characteristics in pregnancies complicated by pre-eclampsia and their association with foetal growth restriction: a cross-sectional study.
- Correlation of amniotic fluid index with severity of pregnancy-induced hypertension: a cross-sectional analytical study.
- Association of oligohydramnios with immediate perinatal outcomes in pregnancies complicated by pre-eclampsia: a prospective observational study.
- Comparison of umbilical artery Doppler indices in gestational hypertension and pre-eclampsia: a comparative cross-sectional study.
- Correlation of umbilical artery pulsatility index with severity of pre-eclampsia: a cross-sectional analytical study.
- Association of abnormal umbilical artery Doppler findings with foetal growth restriction in women with pre-eclampsia: a cross-sectional analytical study.
- Diagnostic utility of umbilical artery Doppler for predicting adverse immediate perinatal outcomes in pregnancies complicated by pre-eclampsia: a diagnostic accuracy study.
- Association of absent or reversed end-diastolic flow in the umbilical artery with immediate perinatal outcomes in severe pre-eclampsia: a prospective observational study.
- Correlation of middle cerebral artery Doppler indices with severity of foetal compromise in pregnancies complicated by pre-eclampsia: a cross-sectional analytical study.
- Association of cerebroplacental ratio with immediate perinatal outcomes in pregnancies complicated by pre-eclampsia: a prospective observational study.
- Diagnostic accuracy of cerebroplacental ratio for predicting adverse immediate perinatal outcomes in hypertensive pregnancies: a diagnostic accuracy study.
- Comparison of umbilical artery Doppler and cerebroplacental ratio for prediction of adverse immediate perinatal outcomes in pre-eclampsia: a comparative diagnostic study.
- Correlation of uterine artery Doppler abnormalities with severity of pre-eclampsia in women undergoing clinically indicated Doppler assessment: a cross-sectional analytical study.
- Association of combined foetal growth parameters, amniotic fluid volume, and obstetric Doppler findings with immediate perinatal outcomes in pre-eclampsia: a prospective observational study.
Intrapartum Management, Mode of Delivery, and Maternal Outcomes
- Pattern of labour and mode of delivery among women with pregnancy-induced hypertension: a cross-sectional observational study.
- Factors associated with caesarean delivery among women with pregnancy-induced hypertension: a cross-sectional analytical study.
- Comparison of mode of delivery in women with gestational hypertension and pre-eclampsia: a comparative cross-sectional study.
- Association of severity of pre-eclampsia with induction of labour and mode of delivery: a cross-sectional analytical study.
- Maternal and obstetric factors associated with successful vaginal delivery after induction of labour in women with pregnancy-induced hypertension: a prospective observational study.
- Comparison of induction-to-delivery interval in women with pregnancy-induced hypertension and normotensive pregnancies: a comparative prospective observational study.
- Association of cervical status at induction with mode of delivery in women with pre-eclampsia: a prospective observational study.
- Factors associated with failed induction of labour in women with hypertensive disorders of pregnancy: a prospective observational study.
- Association of intrapartum cardiotocographic abnormalities with mode of delivery in women with pre-eclampsia: a prospective observational study.
- Correlation of admission cardiotocography findings with immediate perinatal outcomes in women with pregnancy-induced hypertension: a prospective observational study.
- Prevalence and pattern of maternal complications among women with severe pre-eclampsia: a cross-sectional observational study.
- Clinical and laboratory predictors of maternal complications in women with severe pre-eclampsia: a prospective observational study.
- Association of severity of hypertension at admission with need for intensive care in women with pre-eclampsia: a prospective observational study.
- Maternal characteristics associated with acute kidney injury in women with severe pre-eclampsia: a case-control study.
- Risk factors for HELLP syndrome among women with pre-eclampsia: a case-control study.
- Clinical profile and immediate maternal outcomes of women with eclampsia: a retrospective observational study.
- Factors associated with eclampsia among women with hypertensive disorders of pregnancy: a case-control study.
- Association of number of antihypertensive agents required for blood pressure control with severity and immediate maternal outcomes in pre-eclampsia: a prospective observational study.
- Comparison of maternal complications in early-onset and late-onset severe pre-eclampsia: a comparative observational study.
- Association of referral status and delay in presentation with maternal complications in severe pre-eclampsia and eclampsia: a cross-sectional analytical study.
Immediate Perinatal Outcomes and Predictors
- Immediate perinatal outcomes among pregnancies complicated by pregnancy-induced hypertension: a prospective observational study.
- Comparison of immediate perinatal outcomes in gestational hypertension and pre-eclampsia: a comparative prospective observational study.
- Association of severity of maternal hypertension with birth weight and Apgar scores: a prospective observational study.
- Association of early-onset versus late-onset pre-eclampsia with immediate perinatal outcomes: a comparative prospective observational study.
- Maternal and obstetric predictors of low birth weight in pregnancies complicated by pre-eclampsia: a prospective observational study.
- Predictors of neonatal intensive care unit admission among babies born to women with pre-eclampsia: a prospective observational study.
- Association of gestational age at delivery with immediate neonatal morbidity in pregnancies complicated by severe pre-eclampsia: a prospective observational study.
- Association of foetal growth restriction with immediate neonatal outcomes in pregnancies complicated by pregnancy-induced hypertension: a prospective observational study.
- Association of oligohydramnios with Apgar score and neonatal intensive care unit admission in women with pre-eclampsia: a prospective observational study.
- Association of abnormal umbilical artery Doppler findings with birth weight, Apgar scores, and neonatal intensive care unit admission in pre-eclampsia: a prospective observational study.
- Association of abnormal cerebroplacental ratio with immediate neonatal morbidity in hypertensive pregnancies: a prospective observational study.
- Comparison of immediate neonatal outcomes in hypertensive pregnancies with normal and abnormal obstetric Doppler findings: a comparative prospective observational study.
- Association of mode of delivery with immediate neonatal outcomes in women with severe pre-eclampsia: a comparative observational study.
- Relationship between maternal thrombocytopenia and immediate perinatal outcomes in pre-eclampsia: a prospective observational study.
- Association of maternal serum uric acid levels with birth weight and neonatal intensive care unit admission in pre-eclampsia: a prospective observational study.
- Association of maternal serum lactate dehydrogenase levels with immediate perinatal outcomes in pre-eclampsia: a prospective observational study.
- Maternal clinical and laboratory predictors of adverse immediate perinatal outcomes in women with pre-eclampsia: a prospective observational study.
- Predictive value of maternal blood pressure, proteinuria, and routine laboratory parameters for adverse immediate perinatal outcomes in pre-eclampsia: a diagnostic accuracy study.
- Comparison of immediate perinatal outcomes between women with controlled and persistently severe hypertension at delivery: a comparative prospective observational study.
- Combined predictive utility of maternal clinical features, routine laboratory parameters, foetal growth assessment, and obstetric Doppler for adverse immediate perinatal outcomes in pre-eclampsia: a prospective observational study.
Not the obstetrics and gynaecology subspeciality you need? Pregnancy-induced hypertension is one section of our full obstetrics and gynaecology collection — the hub page lists every subspeciality, each with its own free topic list. Updated September 2026.
All Obstetrics and Gynaecology Topics →
📌 Updated for 2026–2027 MD Obstetrics and Gynaecology Pregnancy-Induced Hypertension admissions
The research framework was reviewed for gestational hypertension, preeclampsia, severe maternal disease, organ dysfunction, placental insufficiency, obstetric Doppler and immediate maternal-perinatal outcomes.
- Most projects can be completed with routine blood-pressure recordings, complete blood count, renal and liver function tests, urine protein assessment, fetal biometry, amniotic-fluid assessment, obstetric Doppler and delivery records.
- Research-only angiogenic biomarker testing, additional Doppler examinations, invasive procedures, extra blood sampling or prolonged neonatal follow-up are not required unless clinically justified and specifically approved.
- Publication potential is strongest when the index time is fixed before treatment alters blood pressure or laboratory values, severity is defined by maternal and uteroplacental dysfunction rather than proteinuria alone, and prediction models use variables available before the outcome occurs.
Generate a protocol from any topic above
Select Generate Protocol → beside any title in the list above and receive a submission-ready document built around that topic, containing all eighteen components:
- Introduction / Synopsis
- Research Question
- Aim of the Study
- Primary Objective
- Secondary Objectives
- Materials and Methods
- Inclusion Criteria
- Exclusion Criteria
- Sample Size Calculation
- Methodology
- Statistical Analysis
- Ethical Considerations
- Review of Literature
- References
- Gantt Chart / Study Timeline
- Patient Information Sheet
- Consent Form
- Data Collection Form
Already have your thesis title?
Generate the full pregnancy-induced hypertension protocol directly — objectives, methodology, sample size, statistics, timeline, references and annexures.
Generate your protocol
Alongside pregnancy-induced hypertension protocols and synopses, support is also available for departmental presentations, journal club presentations, ethics committee presentations, and posters and oral presentations for medical conferences — for postgraduate residents, board trainees and research scholars across India and the GCC. Prepared by a practising doctor with long experience in medical publishing and thesis supervision.
Enquire on WhatsApp →
Pregnancy-induced hypertension research outside India
The topics above work as research questions anywhere — what changes is the document the institution expects, and who approves it before data collection begins. The Gulf equivalent of an Indian synopsis is the pregnancy-induced hypertension research proposal submitted to an institutional review board, and it ordinarily carries three sections an Indian synopsis does not: a Gantt chart, a budget and resources section, and a Declaration of Helsinki statement.
Board and residency programmes — country by country
Saudi Arabia — SCFHS and the Saudi Board. Residency and fellowship training under the Saudi Commission for Health Specialties includes a research project with a set timeline, and the pregnancy-induced hypertension research proposal is the document prepared at the outset and cleared by the institutional review board before recruitment starts.
United Arab Emirates — DHA, DOH Abu Dhabi and MOHAP. Residents training in Dubai, Abu Dhabi and the northern emirates prepare a pregnancy-induced hypertension research protocol for their programme and submit it for institutional review board approval before any data are collected.
Qatar — DHP (formerly QCHP) and Hamad Medical Corporation. A pregnancy-induced hypertension IRB proposal is reviewed before recruitment, with the ethics section written to the institution's own template rather than a generic one.
Bahrain — NHRA. Trainees turning pregnancy-induced hypertension research topics into a project need the proposal cleared by their institutional research and ethics committee before fieldwork begins.
Oman — OMSB. Residency programmes under the Oman Medical Specialty Board include a research component, and the pregnancy-induced hypertension research proposal is the document assessed at the start of it.
Kuwait — KIMS. A pregnancy-induced hypertension study protocol goes to the institutional committee for approval before the project begins.
Arab Board programmes across the region. The Arab Board carries its own research requirement irrespective of the host country, and the pregnancy-induced hypertension proposal follows the same structure throughout.
Postgraduate degrees — Malaysia, the Gulf and beyond
Malaysia — MMed, the National Medical Research Register and MREC. A pregnancy-induced hypertension dissertation proposal for a Master of Medicine programme carried out in a Ministry of Health facility must be registered on the NMRR and approved by the Medical Research and Ethics Committee before the study begins, and the guidance asks for submission four to six months ahead of data collection. Every investigator on the study team registers on the NMRR as well, so the methodology, ethics and team sections are written in far more detail than an Indian synopsis requires.
PhD and Master's candidates elsewhere. University programmes generally require a full pregnancy-induced hypertension research proposal of roughly 6,000 to 10,000 words, with an extended literature review, a theoretical framework and a detailed methodology chapter.
PhD and MMed proposals are written individually by a medical doctor and revised until the supervisor accepts them. They are not produced by the automated protocol generator.
Enquire about a pregnancy-induced hypertension PhD or MMed proposal →
🔥 Trending research areas in Pregnancy-Induced Hypertension for 2026–27
Current hypertensive-pregnancy research increasingly combines maternal clinical risk, organ dysfunction, placental biomarkers and fetal surveillance rather than relying on a single laboratory or Doppler parameter.
- Angiogenic biomarker assessment: the soluble fms-like tyrosine kinase-1 to placental growth factor ratio is increasingly studied for short-term risk stratification in women with suspected preeclampsia, although routine availability and local cost remain important practical limitations.
- Validated maternal risk models: tools such as fullPIERS use routinely available symptoms, oxygen saturation and laboratory variables to estimate short-term maternal risk and remain relevant for external validation in different hospital populations.
- Integrated placental and fetal surveillance: fetal growth, umbilical artery Doppler and cerebroplacental assessment can add information in placental insufficiency, but no single Doppler ratio should be used alone to determine outcome or delivery timing.
- Early-onset versus late-onset preeclampsia phenotyping: separating disease by gestational age at onset is increasingly useful because placental dysfunction, fetal growth restriction, maternal presentation and immediate perinatal risk differ between phenotypes.
Protocol and synopsis guidance
What a Pregnancy-Induced Hypertension protocol must contain
A pregnancy-induced hypertension protocol must define the hypertensive disorder being studied, gestational-age limits, blood-pressure measurement technique, diagnostic thresholds, presence or absence of maternal organ dysfunction, fetal-growth criteria and the exact index time used for baseline variables. Gestational hypertension, preeclampsia and preeclampsia with severe maternal or uteroplacental features should not be merged without a prespecified classification rule.
Time-zero must precede major treatment whenever a variable is being used as a predictor. Blood pressure, platelet count, creatinine, liver enzymes, proteinuria and Doppler findings may change after antihypertensive therapy, magnesium sulphate, corticosteroids, fluids, transfer or disease progression. The protocol should therefore state whether the value is the first eligible measurement at presentation, the worst value during admission or a serial measurement. These are different research variables.
Proteinuria should not be used as the sole measure of severity. The protocol should separately record maternal neurological, hepatic, renal, haematological and cardiorespiratory dysfunction together with fetal growth and placental Doppler findings. If a laboratory threshold or combined risk model is evaluated, the primary maternal or perinatal endpoint should be defined independently and before outcome review.
Pregnancy-Induced Hypertension synopsis versus Pregnancy-Induced Hypertension protocol
A pregnancy-induced hypertension synopsis can state that the study will assess clinical risk factors, laboratory severity markers, fetal growth, Doppler findings, maternal complications or immediate perinatal outcomes. The full protocol must convert those aims into reproducible definitions for blood-pressure measurement, disease category, index time, severe features, laboratory sampling, proteinuria assessment, fetal-growth criteria, Doppler technique and outcome timing.
For prediction studies, the protocol should distinguish predictors available at admission from values that appear only after deterioration. For Doppler studies, gestational age, fetal-growth status and interval between the index scan and delivery should be fixed. For induction or delivery studies, mode of delivery should be interpreted as a management outcome influenced by cervical status, fetal condition, gestational age and local clinical practice rather than as a pure biological endpoint.
Sample size and statistical analysis
Sample size should follow the primary endpoint. A prevalence study needs an expected proportion and desired precision; a diagnostic study of a laboratory or Doppler parameter needs enough women with and without the prespecified adverse outcome; and a comparative study of gestational hypertension and preeclampsia requires an expected between-group difference in one primary outcome.
Prediction models need temporal discipline. A variable recorded after acute kidney injury, eclampsia, HELLP syndrome or emergency delivery begins cannot be used as though it predicted that event. Models such as fullPIERS are designed around specified assessment windows and endpoints, so local validation should preserve the original predictor definitions and time horizon rather than creating a new score from the same small dataset without adequate validation.
Repeated blood-pressure, laboratory and Doppler measurements from the same woman are correlated observations and should not be treated as independent participants. Multivariable analyses should account for major confounders such as gestational age, fetal growth restriction, multiple pregnancy, referral status and treatment exposure where relevant. Internally derived cut-offs should be described as local until externally validated.
Frequently Asked Questions – Pregnancy-induced Hypertension Thesis Topics (2026–27)
1. How do I choose a feasible Pregnancy-Induced Hypertension thesis topic for 2026 admission?
Start with the number of women admitted with gestational hypertension, preeclampsia and severe hypertensive disease each month and confirm that first blood-pressure values, laboratory results, urine protein assessment, fetal growth, Doppler findings, treatment timing, delivery details and immediate neonatal outcomes are recorded consistently. A focused study of admission severity, routine laboratory risk markers, fetal-growth restriction, obstetric Doppler or short-term maternal outcome is usually more feasible than a project dependent on expensive biomarkers or prolonged follow-up.
2. Which study designs are accepted for Pregnancy-Induced Hypertension research?
Suitable designs include descriptive and analytical cross-sectional studies, comparative studies, case-control studies, prospective or retrospective cohorts, diagnostic-accuracy studies and prediction-model validation studies. The design should follow the timing of exposure and outcome. Admission profile can be cross-sectional, whereas progression to severe disease, maternal complications, delivery outcome or neonatal morbidity requires longitudinal observation even when follow-up is limited to the index pregnancy.
3. What should I settle with my guide before registering a Pregnancy-Induced Hypertension topic?
Settle the disease definition, gestational-age window, blood-pressure technique, index time, severe-feature criteria, primary maternal or perinatal endpoint, laboratory sampling window, fetal-growth definition and Doppler protocol. Also decide how women transferred after receiving antihypertensives, magnesium sulphate or corticosteroids will be handled because referral and prior treatment can alter the apparent baseline severity.
4. Should proteinuria be used to grade severity of Pregnancy-Induced Hypertension?
Proteinuria is clinically important in the diagnosis and assessment of preeclampsia, but the amount of proteinuria should not be treated as the sole measure of disease severity. Maternal neurological, hepatic, renal, haematological and cardiorespiratory dysfunction together with uteroplacental dysfunction and fetal growth should be assessed separately. A thesis may study proteinuria as one predictor, but the outcome used to define severe disease should not simply reproduce the same protein measurement.
5. What is the difference between a Pregnancy-Induced Hypertension synopsis and protocol?
The synopsis is the concise institutional submission describing the question, objectives, design and broad methods. The protocol is the operational document that fixes disease classification, blood-pressure measurement, index time, laboratory and proteinuria methods, fetal-growth criteria, Doppler technique, severe-feature definitions, treatment exposure, outcomes, confounders and statistical analysis.
6. What ethics issues are important in Pregnancy-Induced Hypertension research?
Clinical stabilisation, antihypertensive treatment, magnesium sulphate, corticosteroids, fetal surveillance and indicated delivery must never be delayed to complete research measurements. The protocol should distinguish routine blood tests, urine protein assessment, ultrasonography, Doppler and cardiotocography from any procedure added solely for research. Research-only venepuncture requires justification and informed consent, with the permitted blood volume stated. Record-based work may qualify for an ethics-approved waiver of individual consent.
Prospective participants should provide informed consent, with guardian consent and age-appropriate assent where an eligible participant is a minor according to institutional requirements and applicable law. Exported ultrasound images and DICOM headers should be anonymised, and separate consent is required for identifiable photographs or video. The escalation pathway should be explicit for severe hypertension, neurological symptoms, thrombocytopenia, rising creatinine or liver enzymes, fetal growth restriction, abnormal Doppler, non-reassuring fetal status or another finding requiring urgent obstetric management.
7. What is the biggest methodological error in a Pregnancy-Induced Hypertension thesis?
The sharpest error is combining measurements taken at different stages of disease and treatment and then calling them all baseline severity markers. A blood pressure recorded before antihypertensive therapy, a platelet count obtained after clinical deterioration and a Doppler study performed just before emergency delivery represent different time points in the disease pathway.
The protocol should therefore define one index time and preserve it for predictor analyses. Later worst values can be studied as markers of progression, but they should not be allowed to predict complications that have already begun. This is especially important when validating maternal risk models or comparing early-onset and late-onset preeclampsia.
8. How does a Pregnancy-Induced Hypertension MD thesis differ from PhD and Gulf board research pathways?
An MD synopsis is usually a focused residency dissertation based on a defined hypertensive-pregnancy population and routine clinical, laboratory and fetal-surveillance data available within one training period. A PhD proposal requires a broader original research programme, a clearer knowledge gap and usually stronger methodological development, biomarker work, multicentre recruitment or longer maternal and offspring follow-up.
Residents beyond the Indian MD pathway should align the project with the mandatory board research project required within SCFHS and Saudi Board training, Arab Board of Health Specializations requirements, and institutional or programme processes linked to DHP, DHA, DOH and MOHAP. Proposal format, supervision, ethics approval, data governance and completion milestones should follow the relevant training authority.
9. When should I register my Pregnancy-Induced Hypertension thesis topic?
Register after confirming case volume, disease definition, index time, primary endpoint, laboratory and Doppler availability and handling of referred or previously treated women, but before prospective recruitment or research-specific data collection begins. For retrospective work, fix the study period and predictor definitions before extracting outcomes so that cases are not selected according to maternal complications, delivery mode or neonatal results already known.
Found a topic that fits your department?
Generate its full protocol — objectives, methodology, sample size, statistics, timeline, references and annexures — in editable format.
Generate your protocol
